Assignee
OLATEC THERAPEUTICS LLC
US·24 granted patents·6 pending applications·20 citations·filing 2015–2023
Top patents by PatentIndex Score
30 records- 0191US11517554B2Method for preventing or treating Alzheimer's diseaseOLATEC THERAPEUTICS LLC·Filed 2020·Granted Dec 6, 2022·2 cites·10 claims
- 0291US9440916B23, 4-bis-benzylsulfonylbutyronitrile and its pharmaceutical useOLATEC THERAPEUTICS LLC·Filed 2016·Granted Sep 13, 2016·3 cites·9 claims
- 0389US9999610B2Pharmaceutical use of 3-benzylsulfonylpropionitrileOLATEC THERAPEUTICS LLC·Filed 2016·Granted Jun 19, 2018·3 cites·3 claims
- 0487US10548870B2Method for treating multiple sclerosisOLATEC THERAPEUTICS LLC·Filed 2019·Granted Feb 4, 2020·2 cites·9 claims
- 0586US9492420B23-methanesulfonylpropionitrile for treating inflammation and painOLATEC THERAPEUTICS LLC·Filed 2015·Granted Nov 15, 2016·3 cites·11 claims
- 0685US11576888B2Methods for treating cardiovascular diseasesOLATEC THERAPEUTICS LLC·Filed 2019·Granted Feb 14, 2023·3 cites·7 claims
- 0785US10500184B23-methanesulfonylpropionitrile for treating inflammation and/or painOLATEC THERAPEUTICS LLC·Filed 2018·Granted Dec 10, 2019·2 cites·13 claims
- 0882US11229620B23-methanesulfonylpropionitrile for treating inflammation and/or painOLATEC THERAPEUTICS LLC·Filed 2019·Granted Jan 25, 2022·1 cites·11 claims
- 0980US9522878B24-methylsulfonyl-2-butenenitrile and its pharmaceutical useOLATEC THERAPEUTICS LLC·Filed 2016·Granted Dec 20, 2016·1 cites·9 claims
- 1080US2023372279A1Pharmaceutical composition for treating inflammation and painOLATEC THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 1173US12318361B2Methods for treating cardiovascular diseasesOLATEC THERAPEUTICS LLC·Filed 2023·Granted Jun 3, 2025·0 cites·8 claims
- 1269US2021059971A1Pharmaceutical composition for treating inflammation and painOLATEC THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
- 1368US10172822B2Pharmaceutical use of 3-benzylsulfonylpropionitrileOLATEC THERAPEUTICS LLC·Filed 2018·Granted Jan 8, 2019·0 cites·16 claims
- 1468US10080735B23-methanesulfonylpropionitrile for treating inflammation and/or painOLATEC THERAPEUTICS LLC·Filed 2017·Granted Sep 25, 2018·0 cites·6 claims
- 1566US10143675B2Pharmaceutical composition for treating inflammation and painOLATEC THERAPEUTICS LLC·Filed 2016·Granted Dec 4, 2018·0 cites·7 claims
- 1666US9770428B23-methanesulfonylpropionitrile for treating inflammation and painOLATEC THERAPEUTICS LLC·Filed 2016·Granted Sep 26, 2017·0 cites·10 claims
- 1765US9750714B2Pharmaceutical use of 3, 4-bis-benzylsulfonylbutyronitrileOLATEC THERAPEUTICS LLC·Filed 2016·Granted Sep 5, 2017·0 cites·12 claims
- 1864US9889111B2Pharmaceutical composition comprising omega-(arylsulfonyl)alkylnitrileOLATEC THERAPEUTICS LLC·Filed 2016·Granted Feb 13, 2018·0 cites·10 claims
- 1963US10751316B2Pharmaceutical composition for treating inflammation and painOLATEC THERAPEUTICS LLC·Filed 2017·Granted Aug 25, 2020·0 cites·6 claims
- 2063US9770429B24-methylsulfonyl-2-butenenitrile and its pharmaceutical useOLATEC THERAPEUTICS LLC·Filed 2016·Granted Sep 26, 2017·0 cites·6 claims
- 2163US9763909B2Methods for treating inflammation and painOLATEC THERAPEUTICS LLC·Filed 2016·Granted Sep 19, 2017·0 cites·5 claims
- 2259US10273203B2Deuterated 3-methanesulfonylpropionitrileOLATEC THERAPEUTICS LLC·Filed 2018·Granted Apr 30, 2019·0 cites·8 claims
- 2358US10441555B2Pharmaceutical compositionOLATEC THERAPEUTICS LLC·Filed 2016·Granted Oct 15, 2019·0 cites·10 claims
- 2457US9592217B2Method for treating skin inflammatory diseasesOLATEC THERAPEUTICS LLC·Filed 2016·Granted Mar 14, 2017·0 cites·5 claims
- 2556US2023330054A1Method for preventing or treating lung infection and lung inflammationOLATEC THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 2653US2022087969A1Method for treating asthmaOLATEC THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 2751US2020170990A1Method for treating schnitzler's syndromeOLATEC THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
- 2850US9815781B1Process for preparing 3-(methylsulfonyl)propionitrileOLATEC THERAPEUTICS LLC·Filed 2016·Granted Nov 14, 2017·0 cites·4 claims
- 2947US9987246B24-benzylsulfonyl-2-butenenitrileOLATEC THERAPEUTICS LLC·Filed 2016·Granted Jun 5, 2018·0 cites·14 claims
- 3042US2016158252A1Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonateOLATEC THERAPEUTICS LLC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →